Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events - PubMed (original) (raw)
. 2015 May;220(5):564-74.
doi: 10.1016/j.imbio.2014.12.006. Epub 2015 Jan 8.
J A S Gomes 2, A Teixeira-Carvalho 1, D Silveira-Lemos 1, D M Vitelli-Avelar 1, R Sathler-Avelar 1, V Peruhype-Magalhães 1, S R Béla 1, K F Silvestre 3, M A Batista 3, N C C Schachnik 1, R Correa-Oliveira 4, S M Eloi-Santos 1, O A Martins-Filho 1
Affiliations
- PMID: 25648688
- DOI: 10.1016/j.imbio.2014.12.006
Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events
A C Campi-Azevedo et al. Immunobiology. 2015 May.
Abstract
In the present study, we characterized the phagocytic capacity, cytokine profile along with the FCγ-R and TLR expression in leukocytes from Chagas disease patients (indeterminate-IND and cardiac-CARD) before and one-year after Bz-treatment (INDT and CARDT). A down-regulation of IL-17, IFN-γ and IL-10 synthesis by neutrophils was observed in CARDT. The Bz-treatment did not impact on the expression of phagocytosis-related surface molecules or monocyte-derived cytokine profile in INDT. Although CARDT showed unaltered monocyte-phagocytic capacity, up-regulated expression of Fcγ-RI/III and TLR-4 may be related to their ability to produce IL-10 and TGF-β. Down-regulation of lymphocyte-derived cytokine was observed in INDT whereas up-regulated cytokine profile was observed for lymphocytes in CARDT. Analysis of cytokine network revealed that IND displayed a multifaceted cytokine response characterized by strong connecting axes involving pro-inflammatory/regulatory phagocytes and lymphocytes. On the other hand, CARD presented a modest cytokine network. The Bz-treatment leads to distinct cytokine network: decreasing the links in INDT, with a pivotal role of IL-10(+) monocytes and expanding the connections in CARDT. Our findings highlighted that the Bz-treatment contributes to an overall immunomodulation in INDT and induces a broad change of immunological response in CARDT, eliciting an intricate phenotypic/functional network compatible with beneficial and protective immunological events.
Keywords: Benznidazole treatment; Chagas disease; Cytokine profile; FCγ-R; Phagocytic capacity; TLR expression.
Copyright © 2014 Elsevier GmbH. All rights reserved.
Similar articles
- Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.
Gomes JA, Campi-Azevedo AC, Teixeira-Carvalho A, Silveira-Lemos D, Vitelli-Avelar D, Sathler-Avelar R, Peruhype-Magalhães V, Silvestre KF, Batista MA, Schachnik NC, Correa-Oliveira R, Eloi-Santos S, Martins-Filho OA. Gomes JA, et al. Immunobiology. 2012 Oct;217(10):1005-16. doi: 10.1016/j.imbio.2012.01.014. Epub 2012 Jan 20. Immunobiology. 2012. PMID: 22387073 - Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens.
Sathler-Avelar R, Vitelli-Avelar DM, Elói-Santos SM, Gontijo ED, Teixeira-Carvalho A, Martins-Filho OA. Sathler-Avelar R, et al. BMC Infect Dis. 2012 May 24;12:123. doi: 10.1186/1471-2334-12-123. BMC Infect Dis. 2012. PMID: 22625224 Free PMC article. - Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
Vitelli-Avelar DM, Sathler-Avelar R, Teixeira-Carvalho A, Pinto Dias JC, Gontijo ED, Faria AM, Elói-Santos SM, Martins-Filho OA. Vitelli-Avelar DM, et al. Scand J Immunol. 2008 Nov;68(5):516-25. doi: 10.1111/j.1365-3083.2008.02167.x. Epub 2008 Sep 18. Scand J Immunol. 2008. PMID: 18803607 - Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Armenti A. Viotti R, et al. Expert Rev Anti Infect Ther. 2009 Mar;7(2):157-63. doi: 10.1586/14787210.7.2.157. Expert Rev Anti Infect Ther. 2009. PMID: 19254164 Review. - Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. Suzuki K, et al. Exerc Immunol Rev. 2002;8:6-48. Exerc Immunol Rev. 2002. PMID: 12690937 Review.
Cited by
- Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC.
Pieralisi AV, Cevey ÁC, Penas FN, Prado N, Mori A, Gili M, Mirkin GA, Gagliardi J, Goren NB. Pieralisi AV, et al. Front Cell Infect Microbiol. 2022 Mar 11;11:785166. doi: 10.3389/fcimb.2021.785166. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35360222 Free PMC article. - A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment.
Pérez-Antón E, Egui A, Thomas MC, Carrilero B, Simón M, López-Ruz MÁ, Segovia M, López MC. Pérez-Antón E, et al. PLoS Negl Trop Dis. 2021 Feb 4;15(2):e0009059. doi: 10.1371/journal.pntd.0009059. eCollection 2021 Feb. PLoS Negl Trop Dis. 2021. PMID: 33539379 Free PMC article. - Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC, Ponce NE, Sanmarco LM, Manzo RH, Jimenez-Kairuz AF, Aoki MP. García MC, et al. Antimicrob Agents Chemother. 2016 May 23;60(6):3700-8. doi: 10.1128/AAC.00404-16. Print 2016 Jun. Antimicrob Agents Chemother. 2016. PMID: 27067322 Free PMC article. - Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease.
Koh CC, Neves EGA, de Souza-Silva TG, Carvalho AC, Pinto CHR, Galdino AS, Gollob KJ, Dutra WO. Koh CC, et al. Pathogens. 2023 Jan 21;12(2):171. doi: 10.3390/pathogens12020171. Pathogens. 2023. PMID: 36839443 Free PMC article. Review. - Benznidazole Anti-Inflammatory Effects in Murine Cardiomyocytes and Macrophages Are Mediated by Class I PI3Kδ.
Cevey ÁC, Mascolo PD, Penas FN, Pieralisi AV, Sequeyra AS, Mirkin GA, Goren NB. Cevey ÁC, et al. Front Immunol. 2021 Dec 2;12:782891. doi: 10.3389/fimmu.2021.782891. eCollection 2021. Front Immunol. 2021. PMID: 34925364 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical